Boehringer Ingelheim Pharma GmbH & Co. KG：

Please note that on January 3, 2025, CFDI sent the Notification of Drug Oversea Inspection Results of Ipratropium Bromide to the agency of the medicine in China.

If there are any questions, please do not hesitate to contact us as soon.

Contact: Gao Shengnan

Tel: +86 10 68441659

Center for Food and Drug Inspection of NMPA

January 3, 2025